Transcript for Long-term effects of COVID-19
Dr. Ashton here. Of course, tracking all of the major developments of course, but we start with our big number, and this is a big and very specific number that's catching our attention today. 530,523, now, that is the number of folks across the country that need to get a first shot, all right, every day, between now and the fourth of July, if we're going to meet that white house goal to have 70% of adults, American adults with at least one jab in the arm by July 4th. Every day. And we obviously know there are a lot of people who are still hesitant to get vaccinated, but there is a new study out that sheds some light that may motivate some people who are on the fence to get their vaccination, of what can happen after you actually get Exactly. And you guys have heard me say before, that there are worse things in medicine than death, and this new study shedding the light on just how debilitating this post-covid syndrome can be. This study found 45% of patients who were hospitalized with covid-19 suffered functional decline upon discharge from the hospital. That means that they were in need of things like assistance with walking, home oxygen, speech therapy, and this was not just in older individuals. Possible causes into this post-covid syndrome, still under investigation. It could be inflammation, it could be a result of an autoimmune response, it could be a combination of both, some of these patients showing signs of autonomic nervous system dysfunction, meaning, difficulty with their heart rate and respiratory rate, just doing everyday things like walking up and down a flight of stairs, so this is significant. And for me, you guys, medically, this was a major motivational factor in getting vaccinated. Take a turn here though, and have blood tests that can detect the return of cancer, that's kind of the headline, and need to get into it a little bit. Exactly, and it's called signatera, it's available throughout the country, being used at major medical centers, cancer centers, it has gotten breakthrough device status by the fda, you guys, and what it is, a simple blood test that in some cases can be done at home that detects fragments of cellular DNA from a patient's specific tumor, so the hope is it can be used to guide treatment in cases of early recurrence. So before a tumor, in terms of recurrence, becomes available, or detectable, you can pick it up on this blood test. So exciting research in the world of cancer. All right, Dr. Ashton, thank you so much.
This transcript has been automatically generated and may not be 100% accurate.